Our Work

Elective surgical suspension during the COVID-19 pandemic resulted in a sizeable surgical case backlog throughout the world. As we ramp back up, how do we decide which cases take priority?

Why doesn't healthcare in the US improve in quality while becoming more affordable, as we see in other industries? Join us for an enlightening discussion with James (Jim) and Robert (Bob) Rebitzer, authors of "Why Not Better and Cheaper?" We explored the unique challenges of healthcare innovation in the US, discussing why there's a lack of incentives for cost-reducing innovations and the ease of profiting from low-value innovations. The Rebitzers also shared their perspectives on directing healthcare innovation towards more efficient and cost-effective solutions. This is a crucial conversation for anyone interested in the future of American healthcare.

Featuring Expert Panelists Jeremey Greene, MD, PhD and Jodi Sherman, MD